Enlil launched Milestone View, designed to help medtech teams replace fragile, siloed timelines with traceable, ...

OpenAI’s GPT-5.3-Codex expands Codex into a full agentic system, delivering faster performance, top benchmarks, and advanced cybersecurity capabilities.

Microsoft is expanding its quantum software stack with new developer tools designed to make quantum application development more accessible, while laying the groundwork for fault-tolerant quantum ...

Microsoft released new open-source quantum development tools, expanding the Quantum Development Kit. VS Code and GitHub Copilot now play a more central role in ...

Games Marvel Rivals owner Netease says heck no we didn't shut down our AI department or warn devs off it Grand Theft Auto Google's Project Genie is "not even in the same ballpark" as a real game ...

Software development used to be simpler, with fewer choices about which platforms and languages to learn. You were either a Java, .NET, or LAMP developer. You focused on AWS, Azure, or Google Cloud.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Henry Chandonnet Every time Henry publishes a story, you’ll get an alert straight to your inbox ...

AI coding tools act like power tools for programmers. Programming jobs will change, but not disappear entirely. New tester and AI-wrangler roles will grow alongside coders. Something terrifying is ...

Of all the possible applications of generative AI, the value proposition of using it to write code was perhaps the clearest. Coding can be slow and it requires expertise, both of which can be ...

Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...

Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...